INTRODUCTION
When Niels Pedersen and coworkers in 1987 first described the feline immunodeficiency virus (FIV), they immediately realized its great potential as a model for human immunodeficiency virus (HIV) studies. The virus was derived from a California domestic cat with clinical features that had led the owner to believe the pet had acquired some kind of AIDS, and it had the typical attributes of a lentivirus (174) . The expectation that FIV would become a leading animal model for HIV studies has since been fulfilled. Indeed, the similarities between the two viruses are so many and profound that persons acquainted with HIV and HIV-induced disease will probably have a feeling of deja vu while reading this article.
Subsequent investigations have shown that FIV is an important health problem for domestic cats throughout the world. Its existence had not been suspected before because, as in HIV infection, the underlying defect is a progressive disruption of the host's immune functions and therefore the clinical manifestations evolve slowly, are polymorphic, and are impossible to attribute to a single etiology in the absence of specific diagnostic tests. Given these premises, it is hoped that studying FIV will not only help us to understand the pathogenesis of HIV and provide clues for the development of interventive strategies for its control but also will benefit the natural host species. This review will principally address the life cycle of FIV in the cat, the immune responses evoked, and the clinical manifestations associated with infection. The state of the art in current attempts to develop efficacious anti-FIV therapies and vaccines will also be a main focus, because it is thought that these attempts might teach a great deal about the best strategies to use in developing an anti-HIV armamentarium. Finally, the pros and cons of FIV as an animal model for AIDS studies will be examined in detail. Several more or less exhaustive reviews on FIV have already appeared (18, 23, 67, 77, 107, 123, 172, 173, 176, 214, 258) . The present update is justified by the accelerating pace at which FIV research has been growing in recent years.
HIGHLIGHTS OF FIV EPIZOOLOGY
Serologic and virus isolation studies have shown that FIV is enzootic worldwide. Its prevalence, however, varies greatly depending on geographical location and other variables of the cat populations surveyed. Among apparently healthy domestic cats, the lowest seroprevalence rates (1% or less) were observed in central European countries and the United States and the highest (up to 30%) were seen in Japan and Australia. Age and gender also markedly affect FIV prevalence. Infection is acquired most commonly after 1 year of age, and its prevalence increases up to 10 years of age and then remains stable or tends to decline (the mean lifespan of domestic cats is about 15 years), most likely as a result of a negative balance between FIV-induced mortality and new infections. Seropositivity rates in male cats are two or more times higher than in females. It is generally accepted that this and other variations in FIV distribution are mainly the result of differences in social behavior and lifestyle of cats which influence the likelihood of FIV transmission (see below). Another important variable that has been seen to affect the results of serosurveys is the health status of the animals. The seroprevalence rates observed were usually several times higher in sick cats than in their healthy counterparts, thus providing a persuasive, though indirect indicator of the disease-inducing potential of FIV (9, 90, 98, 123, 161, 172, 173, 176, 214, 255) .
Evidence of FIV infection has been obtained from cat sera stored as far back as 1968 (202) , and the virus is likely to have accompanied cats for a considerably longer time (212) . Interestingly, although the means of FIV and HIV transmission are considerably different, the spread of FIV infection appears to have a pattern similar to that observed for HIV infection in Africa, where HIV probably had been prevalent long before the epidemic outbreak in western countries (200) . It is not clear whether cats represent the only known reservoir for FIV. There is no evidence that FIV is transmissible to any other species, including humans (123, 126, 255) . Viruses similar to FIV have been documented in several nondomestic felids such as lions, panthers, and bobcats (124, 144, 166) , but it is unlikely that they contribute significantly to the circulation of FIV in domestic cats. Genomic divergences between FIV and lentiviruses isolated from panthers in Florida were so marked as to suggest that the transmission of these viruses between feline species is infrequent or nonexistent (166) .
The precise modes of FIV spread among domestic cats in the natural setting are not yet clear. There is, however, strong circumstantial evidence that biting is by far the predominant means of transmission. The highest prevalences of infection have invariably been found in feral colonies and in adult tomcats with unrestricted outdoor activity, which frequently exhibit aggressive behavior. Also, the gender-related and geographical variations in prevalence mentioned above underline the importance of this route of transmission since males have a greater propensity for biting than female cats and the highest prevalences are found in parts of the world where cats are left free to roam outside ad libitum. On the other hand, a provoked biting experiment has provided convincing evidence that transmission by this route is highly effective (255) . An epidemiological association between FIV and the feline syncytium-forming spumavirus, which is also mainly transmitted by bites, has been observed (9) . A similar association of FIV with the much more easily communicable feline leukemia virus (FeLV) is less certain (9, 35, 98, 255) .
FIV has been demonstrated in the saliva of experimentally and naturally infected cats (132, 135, 255, 259) . Virus isolation was considerably less frequent from saliva than from peripheral blood mononuclear cells (PBMC) . However, PCR analysis demonstrated the presence of both viral RNA and DNA in saliva, suggesting that this fluid contains virus-infected cells or cellular debris as well as free virus. Interestingly, PCR revealed virus genomes in a higher number of saliva samples and with stronger signals than expected on the basis of the virus isolation data (135) . Although anti-FIV antibody is present in the saliva of infected cats (186) , feline saliva did not inhibit FIV growth in vitro. As PCR detection of viral sequences does not prove that infectious virus is present in a sample, the discrepancy between isolation and PCR data was taken to indicate that a large proportion of the virus present in saliva is noninfectious (135) . If confirmed, such a conclusion would help explain the low efficiency of FIV transmission in nature.
Modes of natural FIV transmission other than bite wounds would appear to be rather ineffective. Sexual transmission has never been clearly documented (90) , while vertical transmission has been reported only from queens experimentally infected during pregnancy. In the latter experiments it was impossible to establish whether transmission had occurred in utero (the epitheliochorial placenta of cats is a considerable barrier to cross) or through colostrum, milk, and maternal grooming (28, 126, 176, 240, 245, 255) . Attempts to isolate the virus from colostrum and milk have failed (28, 245, 259) . FIV was isolated from fetal tissues of embryos aborted by a cat in the primary phase of infection (77) .
The risk of fomite transmission is negligible, as FIV is unlikely to survive for long outside the body and environmental contamination has never been associated with significant contagion. Noninfected cats living in close contact with infected cats usually remain seronegative, most likely because cats maintained in stable households for prolonged periods rarely bite each other (240, 259) . However, it has been reported that greater than 50% of the seronegative cats housed for several years with infected companions contained FIV DNA, demonstrable by PCR and in situ hybridization, in their PBMC and bone marrow. The FIV DNA could be transferred to naive animals with blood and bone marrow, but the transfused cats also remained free of recoverable infectious virus, antiviral antibody, and disease (40) . We have confirmed these findings at least partially (17) . The existence of genome-positive but infectious virus-and antibody-negative hosts has been described also for HIV and simian immunodeficiency virus (SIV); however, these findings remain controversial (113, 199) . On the basis of recent data obtained from noninfected individuals exposed to HIV (199) , it would be of interest to evaluate the anti-FIV cell-mediated immune status in seronegative FIV DNA-positive cats.
Experimental transmission is easy by any parenteral route, whether cell-associated or cell-free virus is used. Subcutaneous inoculation has been shown to be an efficient route of infection even in kittens with very high levels of maternal antibody, although scarification of the skin caused insufficient trauma to allow infection. In contrast, experimental transmission through mucosal routes (vaginal, rectal, and with a lower efficiency, oral) required infected cells or large doses of cell-free virus (77, 145) .
THE VIRUS AND ITS GENOME

Morphology and Biochemistry of the Virion
The morphology of FIV has not been studied in great detail. The mature extracellular virion is spherical to ellipsoid, 100 to 125 nm in diameter, and bordered by an outer envelope with poorly defined short projections or knobs. The elongated core is composed of a conical shell that surrounds an eccentric electron-dense nucleoid. A polygonal electron-lucent halo is often visible between the core and a granular layer found just inside the envelope (141, 174, 228, 258) . Thus, the electron microscopic appearance of FIV seems to be indistinguishable from that of other lentiviruses. FIV is rapidly inactivated by chemical disinfectants such as chlorine, quaternary ammonium compounds, phenolic compounds, and ethanol and by heating at 60ЊC for few minutes (172) . Figure 1 shows the presumed location in the FIV particle of the envelope (Env) glycoproteins and the internal protein (Gag) components that have been identified with biochemical or immunological methods or predicted from the study of the viral genome (see below). Each virion also contains two copies of the positive-stranded, polyadenylated RNA genome (about 9,200 bases long) and unknown numbers of molecules of the Pol proteins reverse transcriptase (RT) and dUTPase (DU). As is typical of retroviruses, in the FIV virion Gag proteins are about 20-fold more abundant than Pol proteins (55) .
Env glycoproteins of retroviruses are of importance because they (i) are involved in receptor interactions with cells, thus determining the cell receptor-mediated tropism of the virus; (ii) exert membrane fusion activity (involved in virus penetration and syncytium formation); and (iii) are the primary targets for antibodies and other effectors of immune functions. In the case of FIV, the surface (SU) protein is heavily glycosylated and has an apparent M r of 95,000 (gp95), while the transmembrane (TM) glycoprotein is less glycosylated and has an M r of 40,000 (gp40) (Fig. 2) . Their amino acid compositions have been deduced from the nucleotide sequences of a number of isolates (see below). Such studies have shown that, as in other lentiviruses, the amino acid sequences of Env proteins are highly variable, with up to 20% diversity between isolates. The differences are mainly due to substitutions (deletions and insertions would appear to be less frequent than in HIV), are concentrated in specific segments of the molecule (variable [or VOL. 8, 1995 FIV AS A MODEL FOR AIDS STUDIES 89 V] regions), and generally do not affect glycosylation sites and cysteine residues thought to be crucial for correct folding of the protein. As in other lentiviruses, the V regions of FIV Env proteins (divergences in amino acid sequence of greater than 10%) are interspersed within conserved sequences, designated constant regions (151, 170, 178, 197) (Fig. 3) . Schematic structural models of the spatial folding of the SU and TM glycoproteins have recently been built using predictive algorithms for secondary structures. Interestingly, the resulting models showed considerable similarities to the corresponding molecules of HIV and other lentiviruses (Fig. 2) , leading to the suggestion that Env proteins of lentiviruses rely on a conserved structural framework that tolerates extensive variations in amino acid positions (170) . The major internal components of the virion are the matrix protein of approximately 14.5 kDa, which has recently been shown to be myristoylated (55) ; the capsid (CA) protein of approximately 24.5 kDa; and the nucleocapsid protein of approximately 7 kDa, which contains motifs characteristic of retroviral nucleic acid binding proteins and is believed to be associated with the genomic RNA to form the ribonucleoprotein (50, 216) . The relatedness of the predicted gag gene product of FIV to that of other lentiviruses ranges from 49% amino acid identity with equine infectious anemia virus (EIAV) to 40% with HIV type 1 (HIV-1) (50, 55, 165) .
The purified RT of FIV consists of a single polypeptide of 67,000 M r which is nearly identical to that of HIV RT in template preference, divalent metal ion requirements, and sensitivity to active forms of competitive and noncompetitive inhibitors (156) (157) (158) 196) although considerably different from it in the predicted primary sequence (almost 60% divergence [221] ). Also, the RNase H activity associated with FIV RT displays ion requirements, substrate preferences, catalytic activity, and sensitivity to polyanionic inhibitors very similar to those of the RNase H associated with HIV RT (38, 73) . Approximately one-half of the RT present in the virions lacks the carboxy-terminal RNase H domain (55) . The RT of FIV is believed to be as highly error prone as the corresponding enzyme of HIV, which is considered an important cause of the high genome variability observed in these viruses.
The presence of a virus-encoded DU in FIV, EIAV, and other retroviruses has been recognized recently by Elder and coworkers (54) . The enzyme has an M r of 14,000 and an absolute preference for dUTP. Its function is unknown, but it does not seem to be essential, since several retroviruses including the primate lentiviruses lack DU activity. It has been speculated that by keeping intracellular dUTP levels low during reverse transcription, the potential misincorporation of uracil into viral DNA might be decreased. This function might be especially important during virus replication in cell types that have inherently low levels of cellular DU activity, such as the noncycling macrophages. DU-minus mutants of FIV obtained by insertional mutagenesis replicated more slowly than wild-type virus in transfected PBMC and not at all in primary macrophages (244) .
Genome Organization and Expression
The first isolate of FIV obtained by Pedersen et al. (174) was also the first strain to be characterized at the nucleotide level (164, 221) . Since then, the genomes of a number of FIV strains isolated in different regions of the world have been sequenced completely or partially. FIV diverges from other lentiviruses throughout the genome. Its sequence organization, however, is similar in complexity to that of other lentiviruses, with three large open reading frames (ORFs), gag, pol, and env, encoding the internal structural proteins, the RT and other viral enzymes, and the envelope proteins, respectively, as well as various small ORFs encoding regulatory proteins (Fig. 3) . The structural features of the genome and phylogenetic trees constructed following alignment of the Gag and Pol proteins indicated that FIV is more closely related to the nonprimate lentiviruses EIAV, caprine arthritis encephalitis virus, and visna maedi virus than to primate lentiviruses (129, 165, 178, 221) .
Similar to all retroviruses, the provirus contains two long terminal repeat (LTR) elements, one at each end, which accommodate multiple regulatory sequences. Upstream of the 3Ј LTR is a polypurine stretch and downstream of the 5Ј LTR is a tRNA-Lys primer binding site which are believed to be involved in the initiation of plus-and minus-strand DNA synthesis, respectively (129) . In the FIV proviruses sequenced so far (23) , LTRs have been found to have a length of 355 to 361 bp, similar to those of caprine arthritis encephalitis virus, visna maedi virus, and EIAV and shorter than those of primate lentiviruses (about 460 bp for HIV-1) (140, 165, 221) . Like the visna maedi virus LTR, but unlike the HIV LTR, FIV LTRs appear to be strong basal promoters at least in certain cell types and poorly active in transactivation (142, 215) . Regulatory sequences present in the LTR of FIV include one or two TATA boxes, a consensus polyadenylation signal, one or two sets of imperfect repeats, a CCATT promoter, and a variety of enhancer or promoter protein-binding sites (AP-1, AP-4, ATF-1, EBP20, NF-B, etc.). Such regulatory elements have not been found in all of the FIV isolates sequenced, which might explain the biological differences observed among different isolates (101, 102, 151, 164, 178, 215) . For some such elements, the activity in promoting viral replication has been demonstrated by in vitro mutagenesis of molecular clones of FIV (143, 215) . In HIV and SIV, the R region of the LTR contains a sequence, called Tat responsive element (TAR), which functions as a recognition region for the transactivating protein Tat and has a stem-loop structure that appears to permit the appropriate presentation of the Tat protein. The existence of a similar stem-loop has been described also in the R region of the FIV LTR, but its role, if any, in enhancing FIV replication has yet to be determined (140, 150) . In fact, although a tat-like sequence has been identified in the genome, evidence of the existence in FIV of a transcriptional transactivator is scant (see below).
The gag gene, spanning from approximately base 600 to base 2,000, is initially translated to yield a precursor polyprotein of about 50 kDa in sodium dodecyl sulfate (SDS) gel that is subsequently cleaved to yield (amino to carboxy order) the functionally mature matrix, CA, and nucleocapsid proteins (50, 216) . Cleavage most likely is done by the viral protease (PR). Processing of the Gag 50-kDa precursor did not occur in insect cells infected with a baculovirus expressing the gag gene but not the protease gene of FIV (150, 241) . The precise molecular mass of the mature Gag proteins has been recently determined by Elder et al. (55) , who have also identified most of the proteolytic processing sites within the Gag polyprotein. In particular, the CA protein was found to be processed in a manner very similar to that of HIV.
The enzyme cassette pol gene, which spans from around bases 1,900 to 5,200 and thus overlaps the gag gene by 109 nucleotides, is in a Ϫ1 reading frame with respect to that of the gag gene and is translated as a Gag-Pol fusion polyprotein produced by ribosomal frameshifting, as in other retroviruses. The overlapping region contains a frameshift signal sequence, GGGAAAC, located near the 3Ј end of the gag gene, which is followed by a downstream sequence with the potential to form a tertiary pseudoknot structure apparently essential for efficient frameshifting, at least in baculovirus cells (149, 150) . The ratio of frameshift to readthrough products in this system is estimated to be approximately 30% (149), higher than is observed in HIV. The Gag-Pol fusion precursor protein is eventually processed into the functionally mature enzymes during virus assembly. The Pol portion of the precursor polyprotein (about 1,120 amino acids) is eventually cleaved into (in order of translation) PR, RT, DU, and an endonuclease or integrase, most likely due to autodigestion (54, 55) . The predicted lengths of these enzymes are 123, 559, 130, and about 278 amino acids, respectively (54) . Most recently, the molecular mass of FIV PR was determined to be 14.3 kDa (55) .
The primary translation product of the env gene (which spans from around bases 6,250 to 8,850) is a precursor glycoprotein of 145 to 150 kDa (gp145) that is rapidly reduced in size to a molecule of 130 kDa (gp130), presumably because of trimming of the terminal glucose residues in the rough endoplasmic reticulum. Glycosidase digestion of gp150 and gp130 or treatment of infected cells with tunicamycin resulted in proteins of 100 and 75 to 80 kDa, respectively, indicating that both precursors are heavily glycosylated (218, 241) . The pattern of glycosylation may vary depending on the cell type used for growing the virus (187) . gp130 is subsequently processed into the mature glycoproteins SU (gp95) and TM (gp40) of the viral envelope by proteolytic cleavage in the Golgi complex (218) . These structural proteins, however, do not exhaust the coding potential of the env gene (2,570 bp in the Petaluma isolate). The gene also encodes a long aminoterminal presequence (149 amino acids) which also encodes the first coding exon of the rev gene and a hydrophobic signal peptide (20 amino acids) whose precise functions are not clear but appear to be involved in the proper processing and transport of the SU glycoprotein, from which they are cleaved during maturation (217) .
The sequence of the env gene is the least conserved between FIV isolates. As already alluded to in the description of the mature Env proteins, nucleotide variations are not distributed randomly throughout the env gene but cluster in specific regions ( Fig. 3 and 4) . The number and precise localization of V domains are still under definition. Pancino et al. (170) defined nine V regions, two of which (V1 and V2) are located in the amino-terminal presequence and signal regions; four (V3 to V6), in the SU protein; and three (V7 to V9), in the TM protein (Fig. 2 ). This classification is largely accepted and will be used in this article. Analysis of the rates of silent and replacement substitutions in the variable regions has led to indirect evidence for positive selection of variants, possibly exerted by immune pressure. The rate of change in the env gene has been estimated to be about 3 ϫ 10 Ϫ3 nucleotide substitutions per site per year (70) . Phylogenetic analysis of the nucleotide sequences encompassing the V3, V4, and V5 regions showed that the degree of divergence among isolates is a function of geographical distance and segregation, reminiscent of HIV-1 subgrouping (Fig. 5) (23, 197, 212) . According to a recent study focusing on a 648-nucleotide sequence encompassing regions V3 to V5 of the env gene, by criteria similar to those used to group HIV, isolates of FIV could be divided into at least three distinct sequence subtypes. Pairwise sequence divergence ranged from 18 to 26% between subtypes and from 3 to 15% within each subtype and was as high as 4% within genomes derived from individual infected cats (212) . Further evidence for geographical clustering of genetic variants of FIV comes from recent comparisons of gag and pol sequences of Australian and American isolates (69) . The gag and pol genes are more conserved than the env gene among FIV strains; however, the amino acid sequence of the CA protein of the Japanese isolate TM2 and the Italian isolate Pisa-M2 diverge 5% (129) and 7% (17) , respectively, from that of the Petaluma isolate, and the amino acid sequence of the nucleocapsid protein was found to diverge as much as 20% in the TM2 isolate (129) . The biological significance, if any, of these subtypes in terms of transmissibility, pathogenicity, and vaccine strategies is yet to be understood.
The only two regulatory genes of FIV that have been characterized to some extent are rev and vif. Proviruses of HIV and SIV lacking a functional rev gene cannot produce Gag, Pol, and Env proteins and are replication defective. In FIV, Rev activity has been mapped to two areas: the first exon at the intergenic region from the 3Ј end of the pol gene through the L region of the env gene, and the second exon to the 3Ј end of the env gene (177, 233) . By immunofluorescence, the 23-kDa Rev protein was localized in the nucleus of infected cells. The Rev protein binds to an element, called the rev-responsive element, that in FIV has been mapped to a 243-bp fragment at the end of the env ORF and partially overlaps at the 3Ј LTR and not at the SU-TM protein junction as in other retroviruses VOL. 8, 1995 FIV AS A MODEL FOR AIDS STUDIES 91 ( Fig. 3 ) (177) . In HIV the Rev protein is believed to promote transport of unspliced viral mRNA containing rev-responsive elements from the nucleus to the cytoplasm and also appears to increase the stability of unspliced and singly spliced viral mRNA species containing rev-responsive elements. A recent investigation revealed that, in addition to the genomic FIV RNA, FIV-infected cells contain at least five short FIV-specific transcripts and that the smaller ones are doubly or triply spliced mRNA (233) . Thus, the transcription of the FIV genome is as complex as that of other lentiviruses with elaborate alternative splicing, which suggests the existence of multiple levels of control. Experiments with rev-minus mutants of FIV demonstrated that in the absence of this regulatory factor, no unspliced or singly spliced viral mRNA is expressed and virus production is abolished or diminished (104, 177, 233) . Further studies will be necessary to completely understand the role of FIV Rev in modulating FIV replication. The vif gene (or ORF-1) of FIV is similar in size and location to the vif gene of primate lentiviruses (178, 221) . vif-minus molecular clones of the isolate TM2, once transfected into cells of the fibroblastoid Crandell feline kidney (CrFK) line, replicated in a manner indistinguishable from that of the wild type (232) , but infection with the vif-minus mutant was possible only by cocultivation with infected cells and not with cell-free virus, thus reproducing a biological property of lentiviral vif-minus mutants. The molecular basis of the activity of this gene is not known.
Some other small ORFs present in the FIV genome are conserved in different isolates, suggesting that they perform important functions. However, their functions and RNA transcripts are still poorly understood. Nucleotide homology searches have revealed no obvious similarities between these ORFs and the regulatory gene sequences of HIV and SIV (23) . One such ORF has been partially characterized by Tomonaga et al. (231) . ORF-A (or ORF-2) is similar in location (between the vif and rev genes) (Fig. 3) and size to the first exon of the tat gene in primate lentiviruses. An ORF-A mutant of the TM2 clone retained the capacity to replicate in established CD4 what occurs during a normal infection in cats, it is likely that ORF-A mutant viruses replicate poorly in vivo.
Replication and Effects on Cells In Vitro
In vitro, FIV is tropic for cat T lymphocytes but also infects cells of the monocyte-macrophage-microglia lineage and astrocytes (27, 45, 172) . The similar cell tropism of HIV, and the marked reduction of circulating CD4 ϩ T lymphocytes observed in FIV-infected cats, led to the initial suggestion that, as for HIV, the cat CD4 antigen might be the cellular receptor for FIV. This assumption, however, was soon discarded as subsequent observations showed a lack of correlation between the expression of CD4 on cells and their ability to support FIV replication (26, 250) . In fact, the spectrum of cultured lymphoid cell types that have been shown to support FIV growth upon in vitro infection is wide and includes primary cultures of CD4 ϩ and CD8 ϩ , null T cells, and a variety of interleukin-2 (IL-2)-dependent and -independent, FeLV-transformed or FeLV-free T-cell lines with different surface phenotypes (56, 250, 259) . The conclusion that the CD4 molecule was not involved in FIV entry (at least in vitro) was strengthened by the observation that transfection and stable expression of cloned cat CD4 on nonlymphoid feline cells failed to render these cells susceptible to the highly lymphotropic TM1 and TM2 isolates of FIV (155) . It is noteworthy that, despite this major difference from HIV, FIV infection produces the same effects as HIV infection on CD4 ϩ lymphocytes both in vitro and in vivo.
Recently, Hosie et al. (91) identified a putative non-CD4 receptor by means of a cell-specific antibody designated vpg15 which, although unable to bind the virus, efficiently blocks FIV infection of susceptible cells in vitro. The vpg15 ligand has been characterized as a 24-kDa protein whose expression is consistently decreased when cells become FIV infected. On the basis of reactivity with an anti-human antibody that crossreacts with feline cells, this molecule has been tentatively identified as the feline homolog of human CD9, a marker expressed on a range of cell types of both hematopoietic and nonhematopoietic origin (251) . Alternative routes of entry into cells are possible but have not been demonstrated. Under laboratory conditions, low concentrations of antibody enhance HIV and SIV replication due to facilitated entry into cells via Fc and complement receptors (146) . In vitro enhancement of FIV by subneutralizing concentrations of antibody has been observed, but the receptors involved have yet to be determined (7) .
Different FIV isolates may differ in their in vitro host range even with respect to cells apparently showing the same surface phenotype (100, 178, 232) . The reasons are not known but might involve differences in the Env protein as well as in the composition of the proviral LTR. Miyazawa et al. (142) showed that following transfection of an infectious molecular clone, FIV replicated in some but not all of the otherwise nonsusceptible simian and human cells tested and that in the resistant cells the FIV LTR displayed a much lower level of basal promoter activity than in cells that replicated the virus. Some FIV strains (PPR, TM1, and TM2) could be adapted to grow in CrFK cells, but others could not (141, 178) . Inability to infect these cells seems to be a stable trait as it was conserved in the progeny of infectious molecular clones transfected into CrFK cells (178) . Although CrFK cells express the putative vpg15 receptor marker (91) , the latter experiment and other data suggest that failure to replicate in CrFK cells is not due to a postentry block (129, 140, 142, 207, 209) . It should be noted, however, that the Italian isolate Pisa-M2 could be adapted to grow in CrFK cells only after several passages in the lymphoid cell line MBM (7) . This indicates that the passage history of the virus may affect tropism, possibly because of differences in surface proteins acquired by the virus from the membrane of the host cell (168) . Differences in cell tropism of FIV isolates in vivo have also been noted (236) .
The consequence of FIV infection on cells may vary depending on both the viral isolate and the host cell (148, 230) . In lymphoid cells, cytopathic effects (CPE) usually become evident 7 to 14 days after infection and include cell ballooning, syncytium formation, and cell lysis (174). Willett et al. (250) observed that syncytium formation coincided with a sharp rise in virus production. However, formation of syncytia is pronounced in some cells but is not a general occurrence. For example, syncytia are very evident in CrFK cells adapted to grow in a medium containing a low concentration of serum (237) (Fig. 6 ) but were not noted in infected CD3 ϩ CD4 (136) . During early infection of a T-cell line, cellular death was preceded by ballooning and syncytium formation, but in long-term infected cultures only cell lysis occurred (250) . Syncytia were also formed when human lymphoblastoid cells were exposed to FIV-infected cells or to concentrated FIV. This effect occurred in the absence of viral replication, suggesting that it was produced from the viral material added to the cultures (229) . In a study on the susceptibility of feline neural cells to FIV, Dow et al. (45) noted that astrocytes were the most susceptible and underwent syncytium formation and death, microglial cells productively replicated the virus without obvious CPE, and endothelial cells produced little virus with no CPE. Importantly, oligodendrocytes and neurons remained free of detectable infection and CPE. There are also preliminary indications that FIV isolates can be grouped as syncytium forming and nonsyncytium forming (65) . A recent examination of genetically constructed chimeric viruses indicates that the env region of FIV contains determinants of CrFK tropism but that other determinants may also be involved in tropism (209) . Interestingly, in cultures of CD4 ϩ cells, expression of CD4 antigen was reduced by FIV infection in a fashion similar to that observed with HIV (230, 250) , but CD4 levels returned to normal in chronically infected cells (250) . In the case of FIV, such down-regulation cannot be ascribed to interference due to intracellular binding of the CD4 protein by the viral SU protein as it can be in the case of HIV (113) .
A number of cell lines persistently infected with FIV have been established. These include CrFK cells (259) and several lymphoid cell lines (141, 250, 254) . For example, Yamamoto et al. (257) , by cloning from an IL-2-dependent culture of mixed PBMC of an FIV-infected cat, have developed an IL-2-independent CD4
Ϯ CD8 ϩ T-cell line (FL-4 cells) that produces large quantities of FIV and is presently used in many laboratories as a source of virus for experimental work and diagnostic assays. It should be noted, however, that the FIV produced by persistently infected cells may be consistently less infectious and virulent and induce more feeble antibody responses than non-cell culture-adapted virus (11) . The CPE observed in persistently infected cell lines is low to minimal, although the virus produced retains its CPE capabilities for newly infected cells. However, cell behavior can be affected, as shown by changes in surface marker expression (250) and by the finding that treatment with tumor necrosis factor alpha of persistently infected CrFK cells, but not control cells, led to cellular changes characteristic of apoptosis (162) . The mechanisms responsible for these phenomena were not examined in detail, but it is of interest that similar changes have been observed in cells persistently infected with HIV.
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FIV interactions with macrophages have not been extensively studied. However, there are indications that the virus tends to establish a latent infection in these cells. Freshly harvested peritoneal macrophages were readily infected in vitro, but after an initial burst of viral replication, the RT produced progressively decreased, although there was a concomitant marked increase in number and size of the syncytia produced (27) . In addition, cultures of peritoneal macrophages derived from long-term infected cats expressed little or no RT activity. However, the virus could be reactivated by stimulation with a phorbol ester and cocultivation with fresh PBMC (27, 128) . The ability of the viral genetic information to persist in cells without active virus replication might account for the long latent period of FIV disease.
Intracellularly, the replication of FIV is assumed to proceed along pathways similar to those of the much better understood HIV. Information, however, is scanty. As initiation of transcription is dependent on both viral and cellular regulatory proteins, the rate of viral transcription is markedly affected by the rate of transcription of the infected cell (101, 102, 215) . This can explain why T-cell activation is a prerequisite for productive infection of PBMC in vitro. Studies with baculovirus vectors showed that the unprocessed Gag precursor can assemble, most likely following appropriate myristoylation, into spherical viruslike particles at the cellular membrane and be released as such, without the need for other viral products, while inclusion of the intact PR gene into the gag-expressing vector resulted in efficient processing of the 50-kDa polyprotein into mature Gag proteins and in the failure to produce viruslike particles. These results led to the suggestion that FIV Gag protein cleavage occurs during or after budding of the virions (150) . Following synthesis and processing, the viral envelope glycoproteins are eventually deposited at the surface of the cell (217) . Then, the complex of capsid proteins, replicative enzymes, and viral RNA assembles into a closed spherical particle that buds from the plasma membrane of infected lymphocytes. During this process, the buds have the crescent-shaped appearance of other lentiviruses (258) .
THE INFECTION
Demonstration of FIV Infection
Current methods for detecting FIV infection in cats include virus isolation, immunological tests for virus-specific antibodies or antigens, and molecular tests for FIV genetic sequences. No diagnosis can be made on clinical grounds alone.
By contrast with most other viruses, because of the ability of lentiviruses to persist, an unambiguous demonstration of antiviral antibodies in serum can be considered adequate evidence for ongoing infection. Serological assays for FIV antibodies are rapid and sensitive, and though they provide only indirect markers of infection, they are usually sufficient in veterinary practice for diagnosis of infection. A variety of assays have been described but enzyme-linked immunosorbent assays (ELISAs) using cell culture-derived, gradient-purified virus or recombinant viral core proteins as antigen are by far the most commonly used. Easy-to-use ELISA kits for the detection of anti-FIV antibody are commercially available. The sensitivity and specificity of such assays are usually satisfactory, but false-positive and false-negative results have been reported. False-positive results may arise, especially when the assays are performed with whole-virus lysates and the serum samples are from cats vaccinated for other pathogens which may therefore possess antibody to cell culture components (87, 139, 160, 172, 189, 211, 241, 255) . Indirect immunofluorescence assays are also used but, because they are considerably less specific, should be confined to use for screening purposes.
When needed, ELISA results can be confirmed by Western immunoblotting (WB), radioimmunoprecipitation followed by SDS-polyacrylamide gel electrophoresis analysis, or neutralization (51, 53, 87, 238, 255) . These tests, however, should not be regarded as completely error proof (172) . A recently developed competitive ELISA using CA antigen-specific monoclonal antibodies also proved useful in eliminating false-positive results (122) . WB assays detect antibodies against individual virus proteins and may also be important for studies concerning FIV pathogenesis. Radioimmunoprecipitation also detects antibody that remains occult by immunoblotting (87) . Immunoblotting and radioimmunoprecipitation studies have shown that several virion and precursor proteins and glycoproteins of FIV are immunogenic in infected cats (50, 216) . All sera of naturally FIV-infected cats recognized the Env proteins. Most sera also recognized the CA protein and one or more additional Gag proteins, but a few serum samples showed antibodies only to Env proteins (51, 66) . Antibodies to the Env glycoproteins, however, are usually undetectable by WB when purified virus is used (160), most likely because such molecules are easily sheared from the virion during purification and inefficiently transferred to the nitrocellulose sheets (51, 87) . For this reason, WB methods using FIV-infected cell lysates have been proposed. The interpretation of WB results may be difficult, especially when the strips are prepared with infected cells or poor-quality virus, since protein bands of cellular origin may be formed in positions only slightly different from those of viral proteins. O'Connor et al. (160) regarded as positive the presence of reactivity to two core proteins, while according to Hosie and Jarrett (87), the minimum requirement for a positive WB was the detection of antibody to the SU glycoprotein and to at least three core proteins. Some of the serological assays described above were found to be good predictors of infection when applied to saliva as well (186) . Because saliva in cats is much easier to collect than blood, the performance of saliva-based assays in the field deserves careful evaluation.
The identification of conserved immunodominant B-cell epitopes in the SU and TM proteins (see below) has allowed the development of a peptide-based ELISA and immunoblotting tests that can be useful for diagnostic purposes (6, 42, 64, 120) . Recently, Verschoor et al. (241) , using a recombinant peptide ELISA, found that some infected cats may lack or possess very low levels of antibody to either Gag or Env proteins, thus emphasizing the necessity of testing for antibodies to both viral structures.
FIV isolation is too laborious and time-consuming for routine use and requires well-equipped laboratories and trained personnel; therefore, it is reserved for research purposes. Reportedly, the virus has been isolated from cats that do not show detectable antibody (85) . The virus is usually isolated by coculturing PBMC of infected cats either with primary blast cells obtained by mitogen prestimulation of lymphocytes from naive, specific-pathogen-free (SPF) cats or with cells of certain feline T-lymphoid lines that may be at least as permissive as fresh primary blast cells (65, 136) . The cocultures are usually monitored for Mg 2ϩ -dependent RT and CA antigen production over periods of 5 to 7 weeks. They tend to become virus positive considerably earlier when clinical specimens are derived from diseased cats rather than from asymptomatic animals (9, 135) . By using similar procedures, the virus has also been isolated from several sources other than PBMC (see below). Quantitative coculture techniques that use graded numbers of infected cells have also been used (136, 138) . A point usually not fully appreciated is the ease with which cross-contamination can occur during the long cultivation periods needed for FIV isolation. We encountered this problem when a lentivirus was isolated from an FIV-seropositive sick lion (183) . When the gag gene of this isolate was sequenced, it was recognized as a strain of FIV that is routinely propagated in our laboratory (17) .
Several capture ELISA methods for detecting FIV CA antigen have been developed (40, 122, 211, 227) and are extensively used to monitor virus growth in cell cultures. They can be rendered quantitative by comparing the readings given by the sample with a standard curve calibrated for viral CA antigen. One such method, based on the use of noncompeting monoclonal antibodies and found to detect as little as 0.25 ng of CA protein per ml, has been validated also for detecting antigenemia in infected cats. For optimum sensitivity, acid treatment of sample sera was required to disrupt immune complexes before testing. With this procedure CA antigen was detected in 46% of infected cat sera tested (122) . The available data are still too limited to predict whether the measurement of antigenemia will become a routine prognostic marker in FIV infection as it is in human AIDS (239) . FIV antigens also may be searched for in infected tissues by using immunohistochemistry methods (47, 122, 133, 236) .
So far, FIV genome detection by in situ hybridization has had limited use (14, 15, 40) . Instead, viral DNA and RNA amplification by one or two-step PCR methods has been extensively applied to detect the viral genomes in infected tissues and cell cultures. The primers chosen are located in conserved sequences of the gag, pol, and, less frequently, the env regions (40, 84, 135, 175, 198) . Discrepancies between PCR and isolation or serological results have been described and may stem from a variety of factors, including insufficient numbers of infected cells in the sample and presence of defective integrated proviruses in the cells. PCR methods also carry the threat of false-positive results caused by unrecognized carryover of amplified DNA into experimental samples and other artifacts. The use of multiple sets of primers from different regions of the viral genome and other precautions as well as cautious interpretation of the results are mandatory. There is a great need for simple and reliable quantitative PCR methods for staging the infection and monitoring FIV levels in cats; a limiting cell dilution method (56), a method using an external standard (179) , and one using a deleted internal standard (180) have been described recently but have yet to be fully evaluated.
Host Invasion and Persistence
Little is presently known about where primary FIV replication takes place after its entry in the host, the routes it uses to disseminate within the body, and the time needed for the infection to become systemic. Matteucci et al. (135) isolated FIV from virtually all lymphoid tissues examined as early as 1 week postinfection (p.i.). At this time, salivary glands were the only isolation-positive nonlymphoid tissue. By 3 weeks p.i., however, all nonlymphoid tissues examined, including the brain, yielded positive cultures, while at later times virus isolation from such tissues was less consistent than from lymphoid tissues. Whether and to what extent isolation from tissues reflected local viral replication or the presence of circulating infected PBMC and plasma were not determined. Virus is readily isolated from the PBMC and plasma of experimentally infected cats shortly p.i. (135) . Essentially similar results have been reported by Dua et al. (47) . We currently use plasma of cats infected for 2 weeks as a source of virus for in vivo infection; the titers are approximately 10 3 50% cat infectious doses per ml. Beebe et al. (14) confirmed by in situ hybridization that lymphoid tissues (lymph nodes, tonsils, thymus, spleen, and gut-associated lymphoid tissue) are the VOL. 8, 1995 FIV AS A MODEL FOR AIDS STUDIES 95 primary early targets of FIV. In the first week p.i., the highest concentrations of viral DNA and RNA were detected in the bone marrow, thymus, and lymph nodes and lower levels were found in the other tissues examined, including kidney, lung, and liver. The lymph nodes contained viral genomes mainly in the germinal centers early p.i. and mainly in the extrafollicular areas at later stages. Viral RNA was found in the nonlymphoid tissues solely at later stages of infection and appeared to be present mainly in the interstitium, especially around ducts, in blood vessels, or in inflammatory lesions. Cells other than interstitial mononuclear leukocytes or mononuclear inflammatory cells did not appear to be infected (14) . As discussed, FIV replicates in a wide spectrum of cultured cell types. This, however, does not necessarily reflect the situation in vivo, as it is well known that cell permissiveness to viruses can be modified substantially by culture. Knowledge about the cell types that support FIV replication in vivo is limited. Ex vivo, FIV has been detected in lymphocytes (174) , peritoneal macrophages (27) , and renal (14, 184, 259) and central nervous system (CNS) (14, 46) cells of infected cats. By immunohistochemistry, lymph nodes were shown to contain CA antigen in small lymphocytes, follicular dendritic cells, and (especially during late stages of infection) macrophages (122, 133, 236) . According to Toyosaki et al. (236) , follicular dendritic cells might represent an important target for FIV replication and persistence, although variation in the involvement of these cells by different virus isolates was noted. By double-staining methods, viral antigen-positive lymphocytes were mainly CD4 ϩ T cells. Most notably, no viral antigenexpressing CD8 ϩ T cells were seen. Beebe et al. (14) found that in the first days p.i. 25 to 75% of the virus-positive cells in most tissues were T lymphocytes. The situation, however, changed abruptly when clinical signs of primary infection became evident, as a dramatic increase in the proportion of FIV-infected macrophages and other non-T cells was noted.
Recently, English et al. (56) performed an accurate PCR analysis of lymphocyte subsets sorted from peripheral blood of infected cats. The provirus was detected in CD4 ϩ , CD8 ϩ , and null T lymphocytes and also in a population of immunoglobulin-positive (Ig ϩ ) cells which did not appear to be monocytes and had several markers of B cells. At 2 to 6 weeks p.i., the highest level of provirus was found in CD4 ϩ cells, while from the third month onwards the highest proviral load was found in the Ig ϩ cells (positive signal given by 10 3 cells). Once cultured in vitro, all three cell populations obtained from infected cats produced virus. In contrast, little or no provirus was found in monocytes. As it was impossible to exclude that part of the provirus signal observed was generated by Ig-coated null lymphocytes or other cells, the authors interpreted these findings with great caution. The presence of abundant FIV provirus in B lymphocytes would undoubtedly represent a major deviation from what is known about the cell tropism of other lentiviruses.
The vast majority of bone marrow cells apparently remain virus-free throughout the course of infection. By in situ hybridization, FIV RNA was detected only in limited numbers of megakaryocytes and unidentified mononuclear cells of morphologically abnormal marrows (15) . The latter cells were also positive for viral CA antigen (122) . Systematic studies of the virus burdens found in cats at different stages of infection have yet to be performed. The viral loads found in the PBMC of 11 asymptomatic cats, though extremely variable, were often lower than those detected in 12 symptomatic animals (136) . This finding might indicate that the numbers of proviruscarrying PBMC increase with progression to disease.
Once established, lentiviral infections usually persist for the lifetime of the infected hosts. FIV is no exception. Although anecdotal cases of cats developing a transient viremia not followed by seroconversion or other signs of infection exist, in some studies virus was isolated from 100% of seropositive cats (64, 85) . In other studies a single cultural attempt sufficed to isolate the virus from over 80% of naturally infected cats (135) . Rare cases of truly seropositive cats have, however, failed to yield positive cultures on repeated testing (17) . The mechanisms of FIV persistence in spite of the prompt, intense, and sustained immune responses developed by infected cats have not been investigated. It is likely that several mechanisms among those generally invoked to explain viral persistence are involved, including virus ability to hide in immunocompetent cells, low sensitivity of the virus to serum-mediated neutralization, and antigenic drift. As already discussed, latent infection of macrophages has been described (27) and variability of FIV surface molecules is high. That FIV sensitivity to antibodymediated neutralization is low will be discussed below.
IMMUNE RESPONSES TO THE VIRUS
Immune responses to FIV are still under scrutiny. While cell-mediated responses are still essentially uncharacterized, antibody responses are prompt and vigorous and remain elevated during the long course of infection. The immune response probably contributes to keeping the infection under check, as suggested by the prolonged clinical latency, but fails to entirely eliminate the virus. Whether such acquired immunity is protective against reinfection by different strains of FIV is not known. It is assumed that the persisting virus leads to a progressive derangement of immune functions which eventually renders the host defenseless and the infection ultimately fatal. As brilliantly suggested for HIV (247) , FIV might eventually become its own opportunistic infection.
Antigenic Determinants of FIV
Characterization of FIV antigens is still in its infancy. Because of their potential importance as protective antigens, attention has been mainly focused on envelope glycoproteins. Structural modeling studies based on published FIV nucleotide sequences and screening by ELISA and Pepscan of selected synthetic and recombinant peptides have led to the recognition of several antibody-reactive regions on the SU and TM glycoproteins.
By screening a random peptide library, Pancino et al. (169) identified five regions of the SU glycoprotein which were recognized by variable proportions of infected cat sera; one region appeared to be isolate specific, while the others were more or less extensively broadly reactive. Analysis by Pepscan (Cambridge Research Biochemical, Cambridge, United Kingdom) of the peptide most frequently recognized (amino acid positions 388 to 424) led to the identification of a smaller segment mainly located in the V3 region of the molecule (amino acid positions 398 to 408) which was recognized by 100% of naturally infected cat sera and 88% of sera from experimentally infected animals (6). Lombardi et al. (120) , using partially overlapping synthetic peptides, and deRonde et al. (42) , studying a series of large recombinant peptides, came to similar conclusions. Another important immunodominant domain has been localized at the carboxy terminus of the SU molecule (5, 42, 169) .
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on February 21, 2013 by PENN STATE UNIV http://cmr.asm.org/ region, was recognized by 100% of sera from infected cats. Antibodies to this region of FIV developed within a few weeks p.i. and were maintained at high levels for extended periods (6, 42, 64) . The pentapeptide QNQFF, which is conserved among the several FIV isolates sequenced, was the minimal sequence required for reactivity (6) . Another peptide located closer to the carboxy terminus of the molecule was found to react with 80% of sera from naturally infected cats (6) . Other regions seen by variable proportions of infected cat sera are shown in Fig. 2 . It is of interest that immunodominant sites tend to coincide with variable regions. It has been speculated that this might represent a means of diverting immunologic recognition from conserved segments which are more likely to exert important viral functions (178) . The V3 region of HIV-1 SU glycoprotein contains prominent immunoreactive domains involved in virus neutralization as well as important determinants of cell tropism, cytopathicity, and infectivity (33, 113, 153) . Similar observations have been made for other lentiviruses (8) . Reasoning that the V3 regions of FIV and HIV-1 have a number of structural analogies, including a similar distance from the carboxy terminus of the molecule, the presence of a Cys-Cys bond, a computer-predicted ␤-turn, and a glycosylation site, Lombardi et al. (120) focused on the V3 region of the FIV SU molecule. Analysis of this region by Pepscan and ELISA with four partially overlapping peptides revealed three linear antibody-binding domains, two of which mapped in the amino-terminal part of V3. The immune reactivity of the V3-based peptides was probably due to the presence of both B-and T-cell epitopes because the peptides not only reacted with infected cat sera but also elicited a delayed-type hypersensitivity reaction when injected intradermally into FIV-infected cats (Table 1 ). This study also showed that the V3 region of FIV contains a domain involved in the neutralization of FIV infectivity for the fibroblastoid CrFK cells: the peptide GSWFRAISSWKQRNRWEWRPDF (Fig. 4) inhibited the FIV-neutralizing activity of pooled immune cat sera, and cat sera raised against this peptide effectively neutralized FIV infectivity for CrFK cells (120) . This finding has been confirmed by characterization of a neutralizing serum produced by immunizing rabbits with a recombinant peptide (42) and a neutralizing monoclonal antibody which appeared, however, to bind a conformational epitope (52) . Thus, it would appear that the V3 region could be of great interest as a component of a candidate vaccine against FIV.
It should be mentioned, however, that similar to neutralization of other lentiviruses (146, 153) , neutralization of FIV appears to be a very complex phenomenon. Thus, Siebelink et al. (206, 210) showed that two different single amino acid substitutions in the V4 and V5 regions of the SU glycoprotein (amino acid positions 483 and 560, respectively) conferred resistance to virus neutralization. On the other hand, Baldinotti et al. (7) found that sera of infected cats that exhibited elevated titers of highly efficient, widely cross-reactive neutralizing activity when assayed on CrFK cells exerted a much lower neutralizing effect when assayed in lymphoid cells, which was evident only with homologous virus. Also, at subneutralizing dilutions, sera of infected cats enhanced FIV production by lymphoid cells, a phenomenon not observed with CrFK cells. These quantitative and qualitative discrepancies were attributed to differences in the passage histories of the viral preparations and/or in the characteristics of the cells used, but such possibilities could not be tested because FIV adapted to produce syncytia in CrFK cells proved poorly infectious for lymphoid cells and vice versa. It is worth noting that immune sera also inhibited the fusion of feline FIV-infected cells with human T-cell lymphotropic virus type 1-infected cells (222) .
As is typical of retroviruses, the gag proteins of FIV are abundant in the virion and also highly immunogenic. Indeed, when mice were immunized with purified FIV, the bulk of anti-FIV antibodies was directed against the CA protein.
Epitope mapping of this molecule with murine monoclonal antibodies detected four distinct B-cell epitopes that proved immunogenic also for the natural host (119) . The RT is also immunogenic, as determined by immunoblot analysis and inhibition of enzyme activity (59) . Whether epitopes of the internal virion proteins are expressed on the surface of FIVinfected cells is a matter of great interest for vaccine design and deserves further investigation (122, 134, 154) .
FIV shares important antigen reactivities with lentiviruses recently described in several nondomestic felids (124) . In contrast, antigenic relatedness to other lentiviruses is low. No serological cross-reactions were detected between FIV and primate lentiviruses (165, 258) , and only minor cross-reactivities were seen between the major core proteins of FIV and nonprimate lentiviruses (50, 165, 216) . Sera of horses infected with EIAV also recognized the SU glycoprotein of FIV, but the immunoreactivity was dependent on glycosylation (216) .
Antibody Responses
Though some late seroconversions are occasionally observed (259), after experimental exposure to the virus, serum antibodies to FIV usually become detectable within 2 to 6 weeks depending on virus dose and other variables. Antibodies directed to the major core proteins and to envelope glycoproteins develop at approximately the same time and tend to remain high throughout the lifespan of the infected animal (5, 64, 120, 160, 258) . Antibodies to RT were first detected relatively late in infection and increased over time up to 3 years p.i. (59) . Further studies will be necessary to evaluate whether consistent differences exist in the temporal development of antibodies to individual epitopes and to determine whether they can be used to stage the infection or predict prognosis (64) . Vertically acquired antibodies found in kittens born of FIV-infected queens decline to undetectable levels in 2 to 3 FIV infected
a From reference 17. b Ϫ, negative skin test; ϩ, positive skin test. c SPF cats infected with FIV 5 to 12 months earlier were injected intradermally with 50 g of the indicated synthetic peptides derived from the V3 region of FIV as described in reference 120 or of an irrelevant control peptide and examined for delayed-type hypersensitivity skin reaction 48 to 72 h later.
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months postdelivery, unless the kittens become infected and produce an active response to the virus (28) . The development of FIV neutralizing antibodies has been studied only recently by examining the ability of cat sera to inhibit FIV replication (60, 61) and FIV-induced syncytium formation in CrFK cells (237, 238) . Tozzini et al. (238) found that active production of neutralizing antibodies was evident at 5 to 6 weeks p.i., reached a plateau 3 to 4 months later, and persisted throughout a prolonged observation period. Neutralization was potentiated by complement, an effect that was at least partly attributed to virion lysis (60) . As cat sera obtained from field cats in different geographical areas effectively neutralized different virus isolates, these studies indicated that, like HIV, FIV possesses epitopes capable of inducing broadly reactive neutralizing antibodies (238). As discussed above, one such domains maps in the V3 region of the SU glycoprotein (120) .
Whether the broadly reactive neutralizing antibodies detected by assays performed with CrFK cells play any role in protective immunity in vivo is unknown. Neutralizing antibody titers were similar in symptomatic and asymptomatic infected cats (135) . In vitro exposure to anti-FIV antibody had little effect on the ability of FIV to infect cats: sera with high titers of antibodies that neutralized FIV for CrFK cells failed to inhibit the infectivity for cats of FIV injected intravenously or of FIV infectivity for lymphoid cells (7) . In addition, the likelihood of isolating FIV from saliva and plasma was not related to neutralizing antibody titers in serum or the animal's clinical status (135) . In contrast, adoptive transfer of sera from FIV-infected or vaccinated cats was reported to effectively protect cats against subsequent challenge with the homologous strain of FIV (83) . We cannot exclude, therefore, that in vivo these antibodies contribute to the limit of cell-to-cell spread, especially within nonlymphoid tissues.
Cell-Mediated Responses
Virus-specific, cell-mediated immune responses are presently under close scrutiny in hosts infected with HIV and other lentiviruses, especially with regard to their potential role in vaccine-induced protection. By contrast, this topic has been rather neglected in FIV research to date. There is only one published report dealing with FIV-specific cytotoxic T cells. Target cells consisted of autologous or allogeneic T-lymphoblastoid cells labelled with chromium-51 or indium-111. Fresh or mitogen-and IL-2-stimulated PBMC from infected cats exerted modest levels of cytotoxicity, but their activity was considerably increased following in vitro stimulation with irradiated, FIV-infected autologous lymphoblastoid cells. The effector cells lysed autologous but not allogeneic target cells and were composed predominantly of CD8 ϩ T cells, indicating that the effect was mediated by major histocompatibility complex-restricted T cells. Cytotoxic T cells could be detected as early as 7 to 9 weeks p.i. (213) . Viral antigen-induced lymphoproliferation experiments have been reported for cats infected with FIV (116) or immunized with experimental vaccines (257), but a response was seen only in the latter case.
PATHOLOGICAL EFFECTS
The pathological effects observed in FIV-infected cats may be both a direct consequence of FIV infection and secondary to the immunodeficiency state caused by the virus.
Clinical Manifestations
The development of accurate, commercially available serologic tests has made it possible to identify FIV-infected cats in the field. The illnesses described in such animals are numerous and extremely varied and may be episodic but tend to become persistent with progression (172, 173, 176, 259) . From the observation of field and experimentally infected SPF cats, it has become evident that the FIV disease can be divided into several sequential steps. Ishida and Tomoda (96), on the basis of the type and severity of clinical signs, have proposed a staging of FIV-infected cats into five phases (Table 2) which reflects the classification systems used for HIV-induced pathology. Such staging, which has been widely accepted, is outlined below with the caveat that range and course of clinical signs are extremely variable in individual cats.
Acute phase. In some cases primary infection is clinically silent. More commonly, it manifests itself as a transient illness (1 to 4 weeks) with generalized lymphadenopathy, mild pyrexia, dullness, depression, anorexia, and a neutropenia that in a few cats may allow the development of life-threatening bacterial infections. Acute diarrhea, conjunctivitis, dermatitis, gingivitis, and mild upper respiratory symptoms are also present in more severely affected animals. A few deaths have been recorded, but the link to FIV was not clear. As these early manifestations often respond to supportive and antibiotic treatments, in veterinary practice their etiology frequently escapes recognition (10, 14, 31, 47, 68, 133, 235, 259) .
Asymptomatic phase. After the signs associated with primary FIV invasion have subsided, the infection usually remains clinically inapparent for prolonged periods as occurs with many other retroviruses. In experimentally infected cats, clearcut permanent immunological and hematological alterations do not usually become detectable sooner than 1.5 to 2 years p.i., and clinical manifestations of immunodeficiency appear substantially later, even though infection is usually performed with virus doses presumably much larger than those involved in natural transmission (1, 10, 135, 235) . In fact, many SPF cats infected over the past years in different laboratories with various isolates of the virus are still disease-free. This may be partly because most such cats are maintained in pathogen-free facilities, but epidemiological evidence indicates that in the field also the infection tends to remain clinically silent for years (98, 172, 205) . It is important to emphasize that clinical normality does not imply a virological latency, as shown by the fact that FIV can be isolated from the PBMC, plasma, and (135) . Though the annual rate of progression from the asymptomatic to the symptomatic state and eventually to feline AIDS (FAIDS) is still unknown (95) , it is clear that the evolution of infection is slow, even though from the acute phase a few cats may enter the subsequent symptomatic phases without going through an asymptomatic period. It is noteworthy that the length of the incubation period does not seem to correlate with prognosis (133) . Persistent generalized lymphadenopathy. Persistent generalized lymphadenopathy is characterized by a long-lasting generalized enlargment of lymph nodes. Vague signs of disease, including recurrent fevers, anorexia, weight loss, or nonspecific behavioral changes, are almost invariably present. Overt superinfections are usually absent (98, 172, 255) .
ARC. The acronym ARC, for AIDS-related complex, was introduced in human medicine for indicating a number of manifestations prodromic to full-blown AIDS but not fulfilling the definition of AIDS. The term has been progressively abandoned for humans but remains useful for FIV-infected cats because the natural history of FIV-induced pathology is still poorly understood and a general consensus on the definition of FAIDS is still lacking. Cats in this category usually present with chronic secondary infections of the oral cavity, upper respiratory tract, and other body sites but no opportunistic infections. The agents causing these infections are viruses, including FeLV (35, 71, 90, 96, 202, 255) , feline syncytium-forming virus (9, 255) , feline calicivirus (41, 105, 225, 246) , feline infectious peritonitis virus (98) , feline herpesvirus (193) , feline papillomavirus (49), and poxvirus (24); bacteria, including Staphylococcus sp. (176), Pseudomonas sp. (98), Streptococcus canis (172) , Yersinia pseudotuberculosis (77), nontuberculosis mycobacteria (98, 220) , and other aerobic and anaerobic bacteria (71, 85, 90, 96, 126, 255) ; fungi, including Candida albicans (98, 130) , Cryptococcus neoformans (98, 130) , and Microsporum canis (98, 130) ; protozoa, including Cryptosporidiium sp. (152) and Hemobartonella felis (71, 85, 98) ; and parasites, including Toxoplasma gondii (40a, 98, 108, 167, 253) , Dirofilaria immitis (261) , Demodex canis (32, 176, 220) , Notoedres cati (98, 176) , and Otodectes cynotis (214) .
Weight loss without marked emaciation, generalized lymphadenopathy, fever of undetermined origin, and hematologic abnormalities are common. Other symptoms reported include alopecia and pruritus. Neurologic, renal, neoplastic, and other disorders also may be present in a small proportion of cats. Most, if not all, cases diagnosed as ARC progress to FAIDS after variable time intervals (85, 96, 172) .
FAIDS. FAIDS, similar in many respects to full-blown AIDS of humans, has been observed in 5 to 10% of the clinically ill FIV-infected cats brought to a veterinarian. They suffer from severe secondary infections listed above and, to a lesser extent, from neoplastic and neurologic disorders. The tumors described in FIV-infected cats include high-and low-grade lymphosarcomas, which are frequently extranodal (12, 29, 94, 182, 202) , fibrosarcomas (98) , myeloproliferative diseases (94, 98, 202) , mast cell tumors (12, 202) , squamous cell carcinomas (94, 173) , miscellaneous adenomas and carcinomas (72, 85) , oligodendroglioma (93) , and meningioma (22) . The neurologic abnormalities observed in FIV-infected cats are reviewed in reference 107 and include altered behavior and attitude, convulsions, nystagmus, ataxia, sterotypic motor behavior (repetitive, compulsive roaming), intention tremors, dementia, paralysis (rare), abnormal slow motor and sensory nerve conduction velocities, electroencephalographic alterations, evoked potential abnormalities (prolonged interpeak latencies), magnetic resonance imaging abnormalities (cortical atrophy, ventricular enlargement, and white matter lesions), cerebrospinal fluid abnormalities (pleocytosis, increased IgG levels, and anti-FIV antibody), and histopathological abnormalities. Infections are often multiple, sustained by opportunistic agents, and resistant to treatment. Most animals present with a marked loss of body weight as well as severe anemia and leukopenia. The clinical picture worsens rapidly, and once the diagnosis is made, the mean survival time is usually less than 1 year, in spite of supportive therapy (96, 172) .
In addition to the above stages, Pedersen (172) has proposed a sixth group to include cats presenting with miscellaneous disorders (neurological, neoplastic, ocular, and immunologically mediated, etc.) in the absence of other manifestations that, if present, would allow their inclusion in the previous classification. The usefulness of this all-inclusive additional group is bound to diminish as the disease-inducing potential of FIV is progressively better understood.
Hematological, Immunological, and Other Laboratory Signs
Although the staging of FIV infection is based principally on clinical criteria, the primary defect is the underlying immune dysfunction. This is clearly evident at the levels of both hematological parameters and in vivo and in vitro measurable immune functions.
As in HIV infection, the hematological landmark of FIV infection is a progressive depletion of the CD4 ϩ helperinducer T-lymphocyte subset. In cats infected as young adults, the decline of circulating CD4 ϩ lymphocytes develops in two distinct phases: an early decrease observed during primary infection (47) is followed by a more gradual decline (Fig. 7) . Thus, it is usually only by 1 or more years p.i. that clear-cut CD4 ϩ cell reductions can be unequivocally diagnosed in individual cats. Certain FIV isolates, however, appear to induce more marked and rapid perturbations of lymphocyte subsets than others (234) . Eventually, in terminally ill animals, CD4 ϩ cell numbers may be lower than 200/l (normal range, 1,000 to 3,500/l) (1, 10, 68, 82, 159, 235) . The threshold of CD4 ϩ T-cell drop that is critical for evolution to FAIDS has yet to be established with certainty, but counts below 200/l are usually observed only in diseased cats.
Infected cats also develop an inversion of the CD4 ϩ /CD8 ϩ T-lymphocyte ratio (normal values, Ͼ2) due both to a CD4 ϩ cell decrease and, in some instances, to an expansion of CD8 ϩ suppressor-cytotoxic cells (1, 47, 68, 234, 235, 249) . CD8 ϩ cells also display an upregulation of major histocompatibility complex class II antigen expression (163, 195, 249) . On the other hand, B-cell numbers remain essentially unchanged (1, 159, 234) .
Other hematological abnormalities are also common (204) . In the primary phase a transient leukopenia, due to an absolute neutropenia, is frequent (259) . Cytopenias are usually absent in the asymptomatic phase but occur in a large proportion of cats with ARC and FAIDS (203) . These may be lymphopenias (Ͻ1,500 lymphocytes per l), nonresponsive anemias (hematocrit, Ͻ24%), neutropenias (Ͻ2,500 neutrophils per l), and, less commonly, thrombocytopenias. Multiple concomitant cytopenias are also common (16, 71, 72, 78, 85, 97, 98, 201, 204, 205, 220, 255, 261) . Leukocytosis due to lymphocytosis, monocytosis, and neutrophilia has also been reported in infected cats (85, 255) .
The serum immunoglobulin level (mainly IgG) is almost invariably increased polyclonally in infected cats. This cannot be explained simply by the presence of secondary infections because it occurs also in experimentally infected SPF cats not exposed to others pathogens (1, 85, 186) . Elevated levels of VOL. 8, 1995 FIV AS A MODEL FOR AIDS STUDIES 99 IgG were also found in saliva (186) . The hypergammaglobulinemia correlates with hyperactivation of the B-cell compartment in lymphoid organs as seen histologically (see below) and from enhanced levels of heterophile antibodies and autoantibodies (63) . The levels of circulating immune complexes may also be enhanced (17) . Other biochemical data are generally unremarkable (85) . Abnormalities observed in some cats, such as hyperbilirubinemia (31), generally but not necessarily reflect secondary or concomitant diseases involving specific organs (76) . Increased blood urea nitrogen and serum creatinine (185, 226) indicate a renal damage of unclear etiology (see below). Normal or enhanced antibody responses have been reported (110, 224, 235) , but usually FIV-infected cats mount reduced antibody responses to a variety of antigens and microorganisms (41, 172, 193, 224, 235) . The defects become detectable several months after infection, affect especially primary responses to T-cell-dependent antigens, and may be due partly to impairment of IgM-IgG switching. Symptomatic FIV-infected cats may also exhibit elevated levels of spontaneous or provoked tissue necrosis factor alpha in plasma (110, 111) and of IL-2 receptor alpha-positive PBMC (163) .
Functional abnormalities have also been observed by monitoring immunocompetent cell performances in in vitro tests. These include reduced blastogenic and IL-2 responses of PBMC to T and B mitogens (10, 20, 21, 75, 117, 208, 223, 235) and antigen-specific priming of naive T cells to soluble protein antigens (21) . Some such deficits are detectable soon after infection when circulating lymphocyte subsets are still normal (20, 95, 109, 223) , while others tend to develop at later stages (163, 235) . Interestingly, in vitro mitogen-induced IL-2 receptor alpha expression was depressed in both CD4 ϩ and CD8 ϩ cells, suggesting the existence of functional defects in the latter cell type also (163) . Functional alterations have also been observed in macrophages, neutrophils, and natural killer cell functions of infected cats (74, 115) .
Histopathological Changes
Histopathological changes in lymphoid tissues of FIV-infected cats are remarkably similar to those of HIV-infected individuals. Changes are not so specific as to permit the diagnosis of lentivirus-induced immunodeficiency; nevertheless, they are useful for staging purposes. They vary greatly not only depending on time from infection and other clinical variables but also between individual animals and within lymph nodes of the same animal (30, 172) . There is, however, a general pattern that consists of an exuberant follicular hyperplasia and follicular pleomorphism followed by progressive follicular exhaustion and involution (Fig. 8) .
Cat lymph nodes resemble human ones in morphology and cellular content (30) . During the early stages of FIV infection, the lymph nodes tend to be hyperplastic and show the presence of medium to large secondary follicles in the cortex. Mantle zones vary greatly in thickness, and germinal centers are increased in number and size. Nodular or diffuse expansions of the paracortical T-cell zone and hypercellularity of the sinuses containing lymphoid and histiocytic cells have also been observed. In the asymptomatic phase, the follicular hyperplasia may be temporarily reduced, while in the ARC phase it may again be noted, concurrent with involution. The latter changes include obscure follicular margins, follicular atrophy and segmentation, and hyalinization of the germinal centers. The final stages of the disease process are characterized by marked involution and depletion of the lymph nodes. The cortical follicles become cell depleted or not discernible at all and may contain aggregates of hyaline eosinophilic material; the mantle zones are often indistinct, the paracortical regions are reduced or absent, and the sinuses are collapsed and empty (14, 25, 30, 133, 194) . It should be noted, however, that in a blind study the main feature of FIV-positive lymph nodes, compared with FIV-negative ones, was a higher degree of plasmacytosis (194) .
FIG. 7. Mean absolute CD4
ϩ T-lymphocyte counts, mean absolute CD8 ϩ T-lymphocyte counts, and mean CD4 ϩ /CD8 ϩ T-lymphocyte ratios of cats infected with FIV at birth, as young adults, or in old age. Datum points with a statistically significant difference between infected (E) and noninfected cats (F) are designated with an asterisk (reproduced from reference 68 with permission of the publisher).
Plasma cells were seen to increase in number both within and around germinal centers with progression of infection (30) . In one report of lymphocyte subsets in lymph nodes of FIVpositive cats, a slight increase of CD8 ϩ lymphocytes in the paracortical regions was seen, with no CD8 ϩ cells within follicles (194) . In another study, increased numbers of CD8 ϩ cells were found in germinal centers throughout the year of observation p.i., while CD4 ϩ cell levels initially showed an increase but returned to normal levels within months (30) . These aspects should be further investigated.
Splenic changes appear to parallel the lesions observed in the lymph nodes, while the thymus may show atrophy (14) . The bone marrow of a high proportion of symptomatic cats revealed hypercellularity due to hyperplasia of individual cell lines, maturation abnormalities, lymphoid infiltrates, plasmocytosis, excess eosinophils, and areas of necrosis (14, 131, 204) .
In nonlymphoid tissues histopathological lesions are mainly evident in the advanced stages of infection. In the brain, however, moderate gliosis and glial nodules, sometimes associated with perivascular infiltrates, and white matter pallor were observed as early as 1 or 2 months p.i. depending on whether the virus had been injected intracerebrally or intravenously. Such lesions remained unchanged for 1 year p.i., but in naturally infected animals, presumably infected for longer periods, they were more severe and often accompanied by signs of meningitis (46, 93, 106) . These lesions are similar to the neuropathological findings in people with AIDS (4), though differences have been noted, including fewer or no multinucleate giant cells and a preferential distribution to the subcortical structures in FIV-positive brains. Demyelinization of the spinal cord and vacuolar myelopathy of the dorsal and ventral nerve roots with focal mononuclear infiltrates have also been described (248) .
Kidney abnormalities are frequent and varied. Mesangial widening, with segmental to diffuse glomerulosclerosis, Ig (mainly IgM) and C3 deposits in the mesangium, and severe tubulo-interstitial lesions consisting of diffuse interstitial infiltration by lymphocytes and plasma cells, as well as fibrosis and tubular degenerative changes, have been described in naturally infected animals (185) , and glomerular mesangial cell proliferation has been seen in experimentally infected cats (17, 133) . Recent evidence by Poli et al. (184) indicates that kidney and other organs of FIV-infected cats may also contain amyloid deposits.
Oral lesions are common and usually consist of mild or proliferative gingivitis and periodontitis with or without involvement of extragingival tissues with lymphocyte and plasma cell infiltration. Prominent signs of transmural typhlitis have been described in SPF cats experimentally infected 2 or more months earlier (14) . Cats with chronic diarrhea often show severe and diffuse villous atrophy, particularly evident in the lower intestine and focal areas of mural necrosis, with fibrosis and hyperplasia of the associated lymphoid tissue (25, 31, 259) . Degenerative cardiomyopathy and interstitial pneumonitis have also been seen in recently infected cats (14, 77) , while lesions of the liver (cholangiohepatitis, periportal fibrosis, and biliary stasis) and other organs may be present in sick animals (31, 44) .
USEFULNESS OF FIV AS A MODEL FOR AIDS
It is generally accepted that the areas of AIDS research that can profit most from the study of animal models are (i) illuminating pathogenesis, (ii) development and improvement of antiviral therapies, and (iii) development and testing of protective vaccines. The status in these fields of FIV research is briefly examined below.
Getting a Better Understanding of Pathogenesis
Despite recent advances, our understanding of the HIV developmental cycle in infected individuals and of mechanisms of HIV-induced diseases remains obscure, leading to a considerable uncertainty in the design of rational therapeutic approaches (39, 57, 113, 247) . Studies aimed at understanding how FIV produces pathological effects are still limited, so that it is not certain which paths are most useful to investigate and which will guide us to learn what is most urgent about lentiviral infections of humans. One major issue for study is the role of the direct detrimental action of the virus on immunocompetent cells versus indirect cytotoxic mechanisms in the events leading to CD4 ϩ T-cell depletion and other immunological dysfunctions. In vitro, FIV infection of T lymphocytes is followed by cell lysis in a matter of a few days (discussed above). As reported by Bishop et al. (19) , ex vivo, PBMC from cats infected for 2 to 5 years undergo morphological changes and genomic DNA fragmentation characteristic of apoptosis in the absence of any added stimulation. Whether these phenomena also occur to any significant extent in vivo is not known. Although the number of provirus-carrying PBMC is relatively high throughout infection (136, 138) , the long incubation period and the prolonged course of FIV disease suggest that in the intact animal virus expression must be under some vigorous form of restraint. Indeed, in tissues infected long term, relatively few cells express FIV molecules that are detectable by currently available immunological and molecular techniques (40, 122) . Thus, unless the picture is dramatically changed by the development of more sensitive techniques, serious attempts should be made to understand the factors that keep FIV expression contained so efficiently in the intact animal and unable to do much damage for such prolonged periods of time. Infection is accompanied by a remarkable activation of B cells and the early histological changes are dominated by this phenomenon. Inappropriate activation of the immune system occurs also in HIV infection and has been suggested to represent a fundamental abnormality, with immunosuppression being only secondary to it (39, 57) . The mechanisms of B-cell stimulation by FIV and the antigenic specificity of activated cells, if any, have yet to be determined (63) . It may be worth mentioning that a recombinant peptide incorporating the V3 and V4 regions of FIV SU protein was found to be mitogenic in vitro for naive feline but not human lymphocytes (13) .
Similar considerations apply to the hematopoietic alterations that may be so prominent during FIV infection. The only bone marrow cells that have been shown to harbor the virus are megakaryocytes and macrophages (15, 122) . In addition, bone marrow cell progenitors of infected cats showed a reduced responsiveness in vitro to hemopoietic growth factors, which seemed to reflect the presence of inhibitory substances in serum, but the part these alterations play in the host is not known (118, 201) .
Regarding the numerous other clinical and pathological manifestations associated with FIV, a major problem is to discriminate what is the precise contribution of recognized or unrecognized secondary infections. A direct FIV etiology seems most likely in those pathological lesions and clinical manifestations which are observed at high frequencies in infected cats. Neurological symptoms dominate the picture in about 5% of otherwise asymptomatic cats and accompany other manifestations in a similar proportion of clinically ill animals (78, 205, 220, 243, 255) . While postmortem studies have shown that in naturally infected cats CNS involvement occurs much more frequently than clinically appreciable neurological deficits (46) , kittens infected at 8 months of age showed neuropathophysiological changes analogous to HIV pediatric encephalopathy (181) . As already discussed, FIV can be isolated from the CNS of infected cats in which very high provirus loads can be reached (180) ; the virus replicates primarily in astrocytes and microglia cells (45) . Thus, it seems likely that the neuropathological changes observed in infected cats are mainly, if not solely, due to FIV replication in the CNS, but damage to neuronal functions is mainly indirect. Neurological abnormalities, however, may also stem from superimposed opportunistic infections (81) .
Signs of renal disease have been observed in a high proportion of FIV-infected cats (16, 97, 185, 220, 226) . For example, a recent examination of 326 sick cats living in Australia demonstrated a significant association between FIV infection and hyperazotemia and palpably small kidneys (226) . The virus was easily recovered from renal tissue by isolation and PCR, and occasional tubular epithelial cells as well as scattered interstitial inflammatory cells and glomerular cells stained positive for FIV CA antigen (14, 184) . Thus, it also seems likely that the renal lesions are at least partly a product of local FIV replication in the kidney. However, renal lesions also are frequently observed at postmortem examination in noninfected aged cats (172), so it is also possible that FIV infection simply facilitates the damaging factors responsible for such lesions.
In the field, FIV infection is also associated with a wide range of malignant neoplasms. Tumors are primarily of lymphoid and myeloid origin, but miscellaneous sarcomas and carcinomas also occur, some of which are rare in FIV-negative cats (172) . In different reports, 1 to 28% of FIV-infected cats were found to bear tumors not attributable to FeLV (58, 62, 202, 255, 259) . In FIV-positive, FeLV-negative cats the likelihood of developing leukemia or lymphoma is considerably greater than in noninfected cats, though manifold lower than in cats singly infected with FeLV (202) . Moreover, lymphoand myeloproliferative disorders have been observed in experimentally infected SPF cats free of known tumorigenic viruses (29, 182) . As in AIDS patients (3), the great majority of lymphoid tumors are of B-cell origin. However, as for HIV, studies so far have failed to incriminate FIV in the molecular genesis of such tumors and alternative mechanisms (reduced immunosurveillance, activation of oncogenic viruses, and excess activation of B cells, etc.) have been suggested (29, 182) .
Several attempts have been performed or are under way to evaluate how putative constitutional and exogenous cofactors influence the clinical course of FIV infection. Great (and possibly unjustified) emphasis has been placed on cofactors in the pathogenesis of human AIDS, and due to the prolonged clinical latency before full-blown disease, FIV is an ideal system for these types of studies. A recent investigation examined the effect of age at the time of infection on FIV disease progression over a 10-month period. Cats infected as newborns developed a more profound lymphadenopathy and neutropenia than the other age groups examined. In contrast, lymphocyte subset changes and overall illnesses were more severe in aged cats. Neonates developed ELISA antibody responses to FIV comparable to young adults, while aged cats responded more slowly (Fig. 7) . The conclusion was that aging may be an important determinant in FIV pathogenesis (68) . Age at the time of infection also appeared to influence the virus burdens found in PBMC (138) .
Upon superinfection with FIV, asymptomatic cats with preexistent FeLV infection manifested a more accelerated and exacerbated FIV disease and showed higher FIV loads than did naive cats under both natural and experimental conditions (71, 147, 175) . This interrelationship is similar to what has been described for HIV and human T-cell lymphotropic virus type 1 (113) . Interestingly, the synergy between FIV and FeLV is bidirectional: doubly infected cats developed FeLV-induced tumors more frequently than did cats infected with either virus alone (202) . In addition, FIV-induced histopathological lesions were more evident in cats coinfected with FeLV or feline infectious peritonitis virus than in cats singly infected with FIV (15, 93, 98) . A similar, though less pronounced effect was seen in cats repeatedly immunized with unrelated antigens (112) . A synergistic suppression of mitogen responsiveness was observed in cats concurrently infected with FIV and T. gondii (116) . The clinical significance of findings showing that feline viruses, such as the feline herpesvirus 1 which also infects T lymphocytes, can transactivate FIV LTR is currently unknown (101, 102) .
Contrasting with the above findings, no increase in FIVinduced pathology was seen in cats intentionally exposed sequentially to various pathogens and immunogens over a period of 3 years. As some of the parameters studied were actually better in these animals than in nonmanipulated FIVinfected cats, the suggestion was raised that periodic immune stimulation might in fact ameliorate some of the deleterious effects of FIV-induced immunosuppression (192) . No worsening of FIV disease was noted in cats superinfected with feline syncytium-forming virus (262) . Further studies are warranted to better delineate the role of these and other putative cofactors in FIV infection.
Developing and Improving Therapies
Currently available anti-HIV therapies are only partially effective in controlling virus replication, and their action is often transient because of the frequent emergence of drugresistant viral mutants (99) . In addition, the recent realization that HIV replication is more active through the entire course of infection than formerly believed has raised the dilemma of whether antiviral treatment should be initiated early after infection or in more advanced HIV disease. Deciding is a delicate process because the advantages of starting therapy early must be weighed against the adverse side effects of the available therapies and the enhanced likelihood of favoring an early emergence of drug-resistant strains (57) .
The use of animal models is an essential step in the development of antiviral drugs and combination therapies. With the caveat that even the best animal model is not 100% predictive of human responses, studies in the FIV system can contribute information about the pharmacokinetics and pharmacodynamic properties of candidate anti-HIV compounds and identify potential toxicities, as well as help establish their antiviral potency and optimize the design of clinical protocols. FIV-induced full-blown disease is unsuitable as a criterion for evaluating efficacy of treatments in experimentally infected animals because of the prolonged interval between exposure to the virus and clinical manifestations, although clinical criteria have been advantageously used in naturally infected sick cats. However, as recently pointed out by Barlough et al. (11) , infected cats need not be monitored for prolonged periods, since changes in clinical and hematological abnormalities evident within the first months of infection are sufficient to compare the effects of treatments and other variables. Additional parameters to monitor in recently infected animals are circulating CD4 ϩ lymphocyte counts, which reproducibly decline before severe clinical deterioration, and viral burdens determined by culture or molecular techniques.
As shown in Table 3 , several potential anti-AIDS substances and others already in use have been screened for the ability to inhibit FIV replication and FIV-induced cellular damage in vitro. These include chain termination agents and a number of substances whose mechanisms of action are less well understood. The concentrations required to exert an anti-FIV effect have generally been in the same range as those needed to inhibit HIV. The patterns of cross-resistance to nucleoside analogs of 3Ј-azido-2Ј,3Ј-dideoxythymidine (AZT)-resistant mutants of FIV were similar to those of AZT-resistant mutants of HIV (190) . These findings are in line with what is known about the susceptibility of FIV RT to inhibitors (156, 158) and demonstrate that preclinical in vivo testing of new drugs and new therapeutic protocols are useful approaches in the FIV model. This conclusion is confirmed by the published studies that have tested the prophylactic and therapeutic actions of drugs in FIV-infected animals (Table 4) . In a recent investigation by Remington et al. (191) , two AZT-resistant mutants of FIV reverted rapidly to susceptibility when passaged in the absence of the drug. In the revertants, the single amino acid change responsible for AZT resistance was maintained, no other base changes were noted in the RT coding region, and purified RT remained AZT resistant. These findings suggest the involvement of another genomic region, located outside the RT region, in AZT resistance of FIV. No studies on inhibitors of other viral enzymes have yet been reported. However, the recent chemical synthesis of the PR molecule and its renaturation to an enzymatically active form (55) represent an essential step in the design of PR inhibitors with possible therapeutic applications.
Criteria for Vaccine Development
The development of safe vaccines capable of conferring long-lived and broad-spectrum protection against HIV is proving extremely arduous. After nearly 10 years of research, key questions such as the types of immune responses it would be preferable to elicit (T H 1 versus T H 2 or humoral versus cell mediated), the role exerted by antiviral antibody (protective versus infection enhancing), the set of antigens a vaccine should incorporate (viral envelope versus internal components or both), the kind of the vaccine (technologically modern versus traditional), and even the target to pursue (protection from infection versus protection from disease) remain essentially unanswered. More explicitly, it is still uncertain whether an effective immune prophylaxis against HIV can indeed be achieved by vaccination (34, 80, 199) . The main purpose of using animal models in this area is to provide sound conceptual grounds on which to design candidate anti-HIV vaccines. In this respect, a system such as FIV in which a virus that closely resembles HIV is studied in its natural host species should be most informative. The fact that an efficacious anti-FIV vaccine would be advantageous in veterinary medicine adds value to the system. As clearly emerges from the previous sections, in many areas our present understanding of FIV lags behind knowledge accumulated on HIV. This is inevitable, given the shorter time FIV has been known and the lower number of laboratories involved in FIV research. In contrast, the number of vaccination experiments performed with FIV, using both traditional and subunit vaccine formulations, is relatively high. Unfortunately, most vaccines have failed to induce significant levels of protection, thus confirming the difficulty of developing effective antilentiviral vaccines (171) . Failures have involved vaccines composed of inactivated whole virus, fixed whole infected cells, recombinant CA and SU proteins, and a synthetic peptide corresponding to the V3 region of the SU molecule known to contain a neutralizing antibody-eliciting epitope, delivered in a variety of adjuvants (Table 5) . In some such attempts, FIV infection was actually facilitated in vaccinated animals. Thus, cats vaccinated with purified FIV incorporated VOL. 8, 1995 FIV AS A MODEL FOR AIDS STUDIES 103 into immunostimulating complexes (ISCOM), recombinant p24 in ISCOM, or glutaraldehyde-fixed infected PBMC mixed with the adjuvant quil A became infected more frequently and earlier than unvaccinated untreated cats. As no enhancing antibody was observed in the vaccinated cats, the effect was tentatively attributed to the activation of the immune system associated with repeated immunization (88) . A potentiation of challenge infection was also noted in cats vaccinated with the synthetic V3 peptide mentioned above (17) . Enhancement of infection has also been seen in certain SIV vaccine experiments (219) . Thus, the FIV vaccine scenario would be completely bleak if not for the results reported by Yamamoto and her group. In a first study (257) , these workers developed two vaccines, one consisting of paraformaldehyde-fixed infected cells and the other consisting of paraformaldehyde-inactivated whole virus, which were administered subcutaneously to SPF cats four to six times over 2 to 5 months. The adjuvants used were muramyl dipeptide and a combination of complete and incomplete Freund's adjuvant, respectively. Both vaccines were safe and nontoxic and induced a strong FIV-specific immune response, as shown by ELISA and neutralizing antibodies, as well as proliferation and IL-2 production by PBMC stimulated in vitro with inactivated whole FIV. Vaccinated and control cats that had received either placebo or noninfected cells were challenged intraperitoneally with the homologous virus 2 weeks after the last immunization. As judged by virus isolation and PCR, 13 of 15 vaccinated cats were protected, while all controls were infected. These findings were recently confirmed and expanded to show that vaccinated cats were protected also against a heterologous strain of FIV, differing by 11 and 4% in the amino acid sequence of the SU and TM proteins, respectively, from the vaccine virus (256) , and that immune sera taken from vaccinated cats were also able to protect against FIV infection upon passive transfer into naive animals (83) . Most recently, in a preliminary report, Hosie et al. (89) , using a similar fixed infected-cell vaccine, confirmed the protective effect against homologous virus, but their vaccine was unable to protect against heterologous virus challenge. The reasons for the discrepancies observed in different vaccination experiments reported above are not clear. Even though data indicate that protection can be achieved without the apparent involvement of responses to cellular antigens (92) , in the SIV-macaque model the incorrect use of xenogeneic cells as substrates for producing both the vaccine and the challenge virus has led to misleading results, that is, to protection mediated by immune responses to cellular antigens instead of, or in addition to, immune responses elicited by viral antigens (36) . The incorporation of host cell proteins into lentivirus envelopes is well documented (2, 168) . In the successful FIV studies summarized above, the virus was propagated in feline cells, thus ruling out a role for xenogeneic antigens in protection. In addition, immunization with the cells used to propagate the virus alone did not protect, and no correlation was noted between protection and the antibody response generated against feline cells. Thus, these results seem to support the concept that protective immunity can be achieved with antilentivirus vaccines. However, a note of caution is necessary because the successful FIV vaccination experiments described above have in common the use of FIV (Petaluma strain) propagated in vitro for prolonged periods as a source of immunizing antigen and challenge virus. The possibility that prolonged growth in the absence of immune selective forces has reduced FIV virulence or antigenic polymophism (34, 247) should be considered. Also, a role for allogeneic cell antigens cannot be entirely excluded as the titers of neutralizing antibody were not predictive in distinguishing protected from nonprotected animals (256, 257) . The possibility of successfully vaccinating against FIV should therefore be tested by challenging vaccinated cats with in vivopropagated strains of FIV identical to those circulating in nature. If confirmed, the efficacy of vaccine-conferred protective immunity against cell-associated virus, its duration (antiviral antibody levels declined rapidly in the protected cats [257] ), and its correlates should be assessed. Finally, the effectiveness of the candidate vaccine should be evaluated in the field. Because of the occurrence of natural disease, no other lentiviral model can lend itself to the latter purpose better than FIV.
CONCLUDING REMARKS
With the increasing use of genetically and immunologically manipulated animals, the list of possible animal models of AIDS is expanding (103) . While it is likely that each of the models proposed will provide useful information in specific areas of research, those that in recent years have ranked highest are undoubtedly SIV (43) and, at a certain distance behind, FIV (67) . As is to be expected for any animal model, both viruses show some dissimilarities from HIV, but on the whole, their biology, infection cycles, and diseases closely mimic those of HIV (Table 6 ). The features that have rendered SIV more appealing than FIV as a model system are its closer genetic relatedness to HIV, the fact that the host presumably reacts in a manner more similar to humans than nonprimate animals, and the relatively short incubation period before the onset of overt disease. However, the FIV-cat system, being the smallest natural model of lentivirus infection, has a number of logistical and practical assets that should not be overlooked (Table 6) , and as discussed above, has already proven to be a powerful tool for deciphering the biology, pathogenesis, and susceptibility to drugs and vaccine-induced immunity of immunodeficiency-inducing lentiviruses. The only real logistical drawbacks of studies with FIV are a shortage of immunological reagents and the relatively poor knowledge of the immune system of cats (114) . These two shortcomings are rapidly changing (252) and could be overcome by appropriate fostering of FIV research. Compared with SIV, which is carried as a nonapparent infection in its natural host species, FIV represents a significant affliction for its natural host. Thus, experiments aimed at a better understanding of the virus and the development of effective prophylactic and therapeutic agents will affect only a small number of animals compared with the cat populations that would benefit from the findings. It is hoped that these considerations will help provide further impetus to FIV research.
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